Logo for Voyager Therapeutics Inc

Voyager Therapeutics Investor Relations Material

Latest events

Logo for Voyager Therapeutics Inc

Q3 2024

Voyager Therapeutics
Logo for Voyager Therapeutics

Q3 2024

12 Nov, 2024
Logo for Voyager Therapeutics

Q2 2024

6 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Voyager Therapeutics Inc

Access all reports
Voyager Therapeutics Inc. is a biotechnology company focused on developing gene therapies for the treatment of severe neurological diseases. The company leverages its proprietary platform to create therapies designed to deliver genetic material directly to targeted cells in the brain and other parts of the nervous system. Voyager's research and development efforts focus on treating conditions such as Parkinson’s disease, Huntington’s disease, and other central nervous system disorders. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.